Moreover, TRIM24 overexpression leads to metabolic reprogramming, activating glycolytic and tricarboxylic acid cycle gene signatures, emphasizing its role in the deregulation of cancer-associated pathways, including glucose metabolism, associated with breast tumorigenesis [81]. The gene discussed is TRIM24; the disease is cancer.